Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures)
Launched by CENTRE OF POSTGRADUATE MEDICAL EDUCATION · Dec 22, 2014
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
The role of meniscal in the knee integrity is pivotal and lack or partial role of the meniscus increases rate of joint degeneration. Partial meniscal removal is the most popular procedure and meniscal repair remain in minority of arthroscopic surgeries. As criteria of inclusion to meniscal repair are very rough, still success rates of meniscal repair remain in the 60-80% range for isolated repairs. This rate is greater when performed with ACL reconstruction. We believe that augmentation with bone marrow stimulation techniques will induce more complete and possibly faster healing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Complete vertical longitudinal tear \> 10 mm in length
- • Tear located in the vascular portion of the meniscus, only in red-white zone
- • Unstable peripheral tear
- • Single tear of the medial and/or lateral meniscus
- • Meniscal injury 1 -18 month prior surgery
- • Planned second step arthroscopy (ACL reconstruction)
- • Skeletally mature patients 18-55 years of age
- Exclusion Criteria:
- • discoid meniscus
- • arthritic changes (Kellgren Lawrence scale \>2)
- • non repairable meniscus
- • degenerative or presence of crystals in meniscus
- • concomitant procedure (acl reconstruction, microfracturing, trephination)
- • inflammatory diseases (i.e. rheumatoid arthritis)
About Centre Of Postgraduate Medical Education
The Centre of Postgraduate Medical Education is a leading institution dedicated to advancing medical knowledge and practice through innovative clinical research and education. Committed to fostering excellence in healthcare, the Centre collaborates with healthcare professionals, academic institutions, and industry partners to conduct rigorous clinical trials that enhance patient outcomes and inform best practices. By integrating cutting-edge research with comprehensive training programs, the Centre aims to empower medical practitioners and contribute to the continuous improvement of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Otwock, Woj. Mazowieckie, Poland
Patients applied
Trial Officials
Rafał Kamiński, M.D. Ph.D.
Principal Investigator
SPSK Prof A. Gruca Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials